Native Human IgG1 protein is a Human Full Length IgG1 protein with >95% purity and suitable for SDS-PAGE and ELISA. The predicted molecular weight of ab90283 native protein is 146 kDa.
- Save time and ensure accurate result-use our native IgG1 protein as an isotype control
- No cross-reaction from other immunoglobulin isotypes
View Alternative Names
Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1
- ELISA
Lab
ELISA - Native Human IgG1 protein (AB90283)
The wells were coated with Anti-Human IgG antibody [IG266] (ab200699) at 5μg/ml at 50μl/well overnight at 4°C, followed by a 5% BSA blocking step for 2h RT. Human IgG1 (ab90283) was then added starting at 100 μg/ml and plasma/serum at 1 : 50 and gradually diluted 1 : 4, 50μl/well for 2h. ab201485 was then added at 1 : 10,000 dilution, 50μl/well for 2h. A HRP-streptavidin (ab7403) was used at 1 : 10,000 dilution for 1h.
Reactivity data
You may be interested in:
Why is this recommended?
We recommend this product because it’s often used in the same experiment or related research.
We advise that you always check the datasheet to ensure it fits your experiments, or contact ourtechnical teamfor help.
Product details
The Native Human IgG1 protein ab90283 is prepared from plasma shown to be non reactive for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests.
Ensure the validity of your result using our native human IgG1 protein as an isotype control in SDS-PAGE. Analyze your IgG1 ELISA data using the ab90283 protein to generate and plot a standard curve.
Check out our protein gel staining guide for SDS-PAGE here
Check out our ELISA protocol for more information here.
Protein Determination: Extinction Coefficient (ε) 0.1% at 280 nm = 1.36
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Specifications
Form
Liquid
General info
Function
Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed : 20176268, PubMed : 22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed : 17576170, PubMed : 20176268). Mediates IgG effector functions on monocytes triggering ADCC of virus-infected cells.
Post-translational modifications
Glycosylation on Asn-180 is required for interaction with Fc receptors and ability to activate the complement pathway.. (Microbial infection) Deglycosylation on Asn-180 by S.pyogenes EndoS or Endos2 endoglucosidases prevents interaction between immunoglobulin-gamma (IgG) and Fc receptors, impairing ability to activate the complement pathway.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
The Journal of biological chemistry 300:105623 PubMed38176650
2024
Applications
Unspecified application
Species
Unspecified reactive species
PLoS computational biology 19:e1011109 PubMed37934786
2023
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 13:13166 PubMed37574522
2023
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 12:19759 PubMed36396679
2022
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 11:23491 PubMed34873223
2021
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 9: PubMed34572313
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 30:905-913.e6 PubMed31968262
2020
Applications
Unspecified application
Species
Unspecified reactive species
Arteriosclerosis, thrombosis, and vascular biology 39:1884-1892 PubMed31315438
2019
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 9:1646 PubMed30061898
2018
Applications
Unspecified application
Species
Unspecified reactive species
Journal of immunological methods 455:41-54 PubMed29397157
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Associated Products
Alternative Product
Proteins & Peptides
AB184886
Native Human IgG1 protein
proteins-peptides
native-human-igg1-protein-ab184886
0
(0 reviews)
Alternative Product
Proteins & Peptides
AB155632
Recombinant human IgG1 protein (Active)
proteins-peptides
recombinant-human-igg1-protein-active-ab155632
0
(0 reviews)
Alternative Product
Proteins & Peptides
AB180055
Recombinant Mouse IgG1 protein
proteins-peptides
recombinant-mouse-igg1-protein-ab180055
0
(0 reviews)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com